1. Home
  2. KEQU vs ONCY Comparison

KEQU vs ONCY Comparison

Compare KEQU & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

HOLD

Current Price

$35.62

Market Cap

110.9M

Sector

Industrials

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.80

Market Cap

107.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KEQU
ONCY
Founded
1906
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.9M
107.3M
IPO Year
1995
2002

Fundamental Metrics

Financial Performance
Metric
KEQU
ONCY
Price
$35.62
$0.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.33
AVG Volume (30 Days)
4.4K
1.5M
Earning Date
03-11-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.22
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
$11.18
N/A
Revenue Growth
7.72
N/A
52 Week Low
$33.27
$0.77
52 Week High
$60.89
$1.51

Technical Indicators

Market Signals
Indicator
KEQU
ONCY
Relative Strength Index (RSI) 48.43 41.24
Support Level $35.15 N/A
Resistance Level $41.25 $1.06
Average True Range (ATR) 0.99 0.07
MACD -0.00 -0.01
Stochastic Oscillator 28.20 6.19

Price Performance

Historical Comparison
KEQU
ONCY

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: